secwatch.observer — SEC 8-K summary
======================================

Issuer:     CAPRICOR THERAPEUTICS, INC. (CAPR)
CIK:        0001133869
Form:       8-K
Filed at:   2024-01-11T23:59:59+00:00
Accession:  0001558370-24-000197
Event type: other_material
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Capricor receives $10M milestone from Nippon Shinyaku; HOPE-3 trial continues
-----------------------------------------------------------------------------

- Milestone payment of $10.0 million received from Nippon Shinyaku under 2022 commercialization agreement.
- Payment triggered by favorable interim futility analysis from Data Safety Monitoring Board for HOPE-3 trial.
- DSMB recommended continuation of HOPE-3 trial as planned.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1133869/000155837024000197/0001558370-24-000197-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1133869/000155837024000197/capr-20240111x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-000197

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer